Tue, August 10, 2010
Mon, August 9, 2010
Fri, August 6, 2010
Thu, August 5, 2010
Wed, August 4, 2010
Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010
[ Tue, Jul 20th 2010 ] - Market Wire
00 AM EDT
Mon, July 19, 2010

Somaxon Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. -10th-annual-focus-on-healthcare-conference.html
Published in Health and Fitness on Thursday, July 29th 2010 at 5:16 GMT by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference at The Sheraton New York Hotel and Towers in New York City on Thursday, August 5th at 10:45 a.m. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for 6 months following the conference.

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor® (doxepin) has been approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the companya™s web site at [ www.somaxon.com ].


Publication Contributing Sources